Carnagarin, R.; Tan, K.; Adams, L.; Matthews, V.B.; Kiuchi, M.G.; Marisol Lugo Gavidia, L.; Lambert, G.W.; Lambert, E.A.; Herat, L.Y.; Schlaich, M.P.
Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—A Condition Associated with Heightened Sympathetic Activation. Int. J. Mol. Sci. 2021, 22, 4241.
https://doi.org/10.3390/ijms22084241
AMA Style
Carnagarin R, Tan K, Adams L, Matthews VB, Kiuchi MG, Marisol Lugo Gavidia L, Lambert GW, Lambert EA, Herat LY, Schlaich MP.
Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—A Condition Associated with Heightened Sympathetic Activation. International Journal of Molecular Sciences. 2021; 22(8):4241.
https://doi.org/10.3390/ijms22084241
Chicago/Turabian Style
Carnagarin, Revathy, Kearney Tan, Leon Adams, Vance B. Matthews, Marcio G. Kiuchi, Leslie Marisol Lugo Gavidia, Gavin W. Lambert, Elisabeth A. Lambert, Lakshini Y. Herat, and Markus P. Schlaich.
2021. "Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—A Condition Associated with Heightened Sympathetic Activation" International Journal of Molecular Sciences 22, no. 8: 4241.
https://doi.org/10.3390/ijms22084241
APA Style
Carnagarin, R., Tan, K., Adams, L., Matthews, V. B., Kiuchi, M. G., Marisol Lugo Gavidia, L., Lambert, G. W., Lambert, E. A., Herat, L. Y., & Schlaich, M. P.
(2021). Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—A Condition Associated with Heightened Sympathetic Activation. International Journal of Molecular Sciences, 22(8), 4241.
https://doi.org/10.3390/ijms22084241
